chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 101 patients. This report refers to one of the patient's involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 26-JUN-2013 (lot # H021608, Expiration Date: 13-AUG-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vaccines were applied to patients after being refrozen). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment information was reported by the reporter.
Complex febrile seizure (status > 17 minutes) approximately 24 hours after vaccines. No other symptoms. No history of seizures.
swelling; rash; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling) and RASH (rash) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling) and RASH (rash). At the time of the report, SWELLING (swelling) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow up received on 08-Jun-21 included Non significant information
Arm and shoulder soreness directly after injection in the arm on 10/13/2020. By mid afternoon that day a large red welt began to form at injection site and was itchy and burned. The red welt lasted about 7 to 10 days and the arm and shoulder soreness remained. I gradually began losing range of motion in my arm and shoulder and have constant pain with use and relaxing 06/28/2021.
pt recv vax 7MAR96 & 17MAR96 pt broke out in a chicken pox rash all over body;no further details were provided;
Had chills all night - from  ~ 5pm until 5am on the 30th. @  5 am om the 30th - I had intermittent periods of chills - but much less severe. Also had a temp of 100,2 w/ slight headache. Started taking tylenol about 3 am on the 30th.; then every 6 hours after. Did stay in bed - slept basically until 9am - this date 1/31/21. Although I think this was a "normal" reaction - just thought I should report it - to add to generally data about the vaccine.
January 5th began excessive urinating, dry mouth, nose, headache & fatigue. January 13, 2022, EMTs transported unresponsive patient yo the Hospital ER. Ended up in ICU for 5 days. Autoimmune attack on pancreas causing Type 1 diabetes in previously healthy/fit 70 yr old woman. Extreme blood sugar numbers: 1332. Now on insulin injections 5x per day.
he has ongoing bad taste in her mouth; lost her memory; pain in her back; upset stomach; Pain in her teeth; dizzy; rash; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (he has ongoing bad taste in her mouth), AMNESIA (lost her memory), BACK PAIN (pain in her back), ABDOMINAL DISCOMFORT (upset stomach) and TOOTHACHE (Pain in her teeth) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TASTE DISORDER (he has ongoing bad taste in her mouth), AMNESIA (lost her memory), BACK PAIN (pain in her back), ABDOMINAL DISCOMFORT (upset stomach), TOOTHACHE (Pain in her teeth), DIZZINESS (dizzy), RASH (rash) and FATIGUE (fatigue). At the time of the report, TASTE DISORDER (he has ongoing bad taste in her mouth) had not resolved and AMNESIA (lost her memory), BACK PAIN (pain in her back), ABDOMINAL DISCOMFORT (upset stomach), TOOTHACHE (Pain in her teeth), DIZZINESS (dizzy), RASH (rash) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-148081 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: Follow-up received: Route of administration and outcome of the events was updated.
past the 12 hours post puncture and staff vaccinated patients; Approximately 72 hours; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (past the 12 hours post puncture and staff vaccinated patients) and PRODUCT STORAGE ERROR (Approximately 72 hours) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (past the 12 hours post puncture and staff vaccinated patients) and PRODUCT STORAGE ERROR (Approximately 72 hours). On 06-Dec-2021, EXPIRED PRODUCT ADMINISTERED (past the 12 hours post puncture and staff vaccinated patients) and PRODUCT STORAGE ERROR (Approximately 72 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Not enough sterile diluent was added to the vial of Pfizer vaccine prior to administration, therefore patient did not receive enough of the mRNA to qualify as a booster dosage.
Pt states she had a hive one to two inches below injection site and itchy hives covering her body.
Myalgia, NauseaVomiting, chills Narrative:  Employee reports chills, body aches, and nausea in the  middle of the night following receipt of the 2nd dose of the vaccine. Report using Tylenol for symptom relief.
After receiving the vaccine, later that night I started to have lower back pain and I  am still suffering from the same pain.
18OCT95 330AM itching, raised rash, urticaria rt sided scalp, neck pectoral, rt flank & groin, ER visit;19OCT95 progressed to lt side of body from scalp to groin;20OCT95 progressed to face, arms, legs, hands & feet back pvt MD tx w/Pred
Vaccine administered after use by date.  Efficacy study done by Moderna and vaccine dose deemed effective, no re-vaccination needed.  Moderna Case ID Unknown.
Redness, swelling, raised area that extends from below elbow to shoulder. Achy feeling all over and tiredness.
recent COVID infection diagnosed on 02/03 after he was exposed to positive healthcare workers, in a routine weekly test performed by the facility
itchiness and redness at the injection site; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness and redness at the injection site) and FATIGUE (fatigue) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced FATIGUE (fatigue). On 16-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness and redness at the injection site). On 14-Jan-2021, FATIGUE (fatigue) had resolved. At the time of the report, VACCINATION SITE PRURITUS (itchiness and redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment include cortisone cream.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Day 1 some fatigue and headache. Day 2 Severe Fatigue, headache, dizziness, mild nausea, chills, body aches. Day 3, 102 fever. Severe chills, body pains, nausea, vomiting, diarrhea, headache. Pain and swelling in the arm but manageable. Covid test Saturday on Day 3, negative.  Day 4 same as day 3. Could not drive due to feeling faint. Day 5 & 6 nausea still medium. chills and fever still present. Tested again for covid on Tuesday (day 6) due to headaches, nausea, body aches still present. Day 7,  nausea and fatigue and chills. Day 8 woke up with huge swollen arm. it's hot, itches and very very swollen - 4" long and is painful. Medications taken on schedule Tylenol 500 mgs every 4 hrs and Advil 600 mgs every 6.  Day 8 still nauseated.
10-3-15 101.5 temp, dizzy, rash on left deltoid, hot, firm, red at site of inject seen by Dr. 10-4-15 at 4 AM temp 103.8. No breathing problems. 10-5 low grade fever.
Client received pneumonia polysaccharide vaccine 0.5 ml IM in right deltoid on 10/23/2007. (Had received Fluzone vaccine in same arm on 10/18/2007.)  Administering nurse reports no unusual appearance to arm, etc., and client expressed desire to receive the pneumonia shot in the same arm because of pre-existing lymphadema in the left arm.)  Client returned to Health Department on 10/25/2007 with c/o redness at site occurring on 10/24.  Nurse practitioner examined client's arm and noted no redness or localized swelling at injection site, but noted redness and swelling on inner aspect of left arm.  Encouraged to have area evaluated by her physician and let the Health Dept know his opinion.  The client was not back in contact with the Health Dept until 11/26/2007 when she requested and was given the record of her pneumonia shot administration and a copy of note regarding her 10/25 presentation, reportedly to be taken to her physician.  A note to him was included at the bottom of the record requesting he advise us of his final diagnosis.  This was never received, and the client was vague as to the actual physician's name.
Approx 30 sec p/vax pt grimaced, became pale & had dec muscle tone; eyes rolled back & had 3 jerking movements of head & arms; episode lasted only a few seconds; pt felt nauseated;
pt recv vax & devel an unspecified rxn;this is 1 of 3 pt from this site to report adverse rxn to lot# 431965
Pt has moderate swollen lymph nodes into her neck on the arm the vaccine was given.  No fever but achy and nauseous.
Ever since a few days after my second dose of the Pfizer COVID-19 vaccine I've had a very weird feeling in my right armpit. It's a weird numbing feeling. It happens when I slightly move my arm around. It has not gone away and it's been nearly two months. I do not have a primary care doctor nor do I have health insurance. I would like this incident to be looked into as I fear this side effect is not going to go away.
About a week after vaccine was administered, developed red area on arm that is sporadically itchy.  Perhaps slightly swollen and slightly warmer than rest of arm.  About hand size, extending from side of arm around injection location downward towards front of arm.  Now on about 4th day. Note:  my 43 year old daughter had same reaction and reported it.
Information has been received from a health professional concerning a patient in the second grade who was vaccinated with a dose of Varivax. On 01-MAR-2006 the patient experienced chickenpox. Additional information has been requested.
VERTIGO, PHYSICAL THERAPHY, FOGGINESS OR FUNNY FEELING IN HER HEAD.
pt recvd vax JUL95 & 3 wks later approx 19JUL95 pt devel blister-like lesions on the lip & a generalized rash;over the next 2 days devel 20 to 25 lesions on the inside of mouth & lesions on the cheek & zygoma
7AM -PATIENT FELT DIZZY AND WARM AND SWEATY - PASSED OUT  - VOMITED   8:30AM - PATIENT FELT DIZZY AND WARM AGAIN
Information has been received from a nurse concerning a 10 year old male who on 17-JUN-1996 was vaccinated with varicella virus vaccine live (Oka/Merck). On 13-MAR-2006 the patient had an onset of chicken pox break thru. Subsequently the patient recovered. No treatment was necessary, just comfort measures as needed. The nurse also reported on two other patients who experienced adverse events being vaccinated with varicella virus vaccine live (WAES#0602USA05682 and #0703USA05016) Additional information is not expected.
high Sediment rate= 35; high Granulocyte count; A spontaneous report was received from a consumer concerning a 68-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events high sediment rate= 35/red blood cell count increased, high granulocyte count/granulocyte count increased.  The patient's medical history was not provided. Concomitant medications reported were Imuran, Methotrexate for sarcoidosis and Levofloxacin, Prednisone 1mg tablet, Potassium Chloride 20meq BID for drug use for unknown indication.  On 3 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 011M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) high Sediment rate= 35, high Granulocyte count.  Treatment details included Levaquin.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), high sediment rate= 35, high granulocyte count was unknown.
This case was reported by a physician to a sales representative and described a patient who did not respond to the Hepatitis A component of immunization with Hepatitis A inactivated and Hepatitis B recombinant vaccine (Twinrix).  The physician reported that approximately 30 patients did not respond to the Hepatitis A component of Twinrix, however, identifiers were not provided.  On an unspecified date, the patient completed the Twinrix immunization series.  Subsequently, on an unspecified date, a Hepatitis A antibody titer indicated that the patient was non-immune.
ITP developed w/in 2 wks of vax. It was unresponsive to IVIG & steriod therapy caused side effects & altered life-style. splenectomy resolved sxs.
p/ pt recv vax the same day pt devel injection site warmth, redness, swelling 5cm firm area, tingling in lower left arm & a temp of 99.3f. pt took Benadryl & applied cold compresses
Painful papular rash spread out on bilateral lower and upper extremities. Right arm where vaccine was given, patient reports radiating pain to armpit and lateral chest.
Pain at site, fever up to 101.5, muscle aches, fatigue and chills
ED Course/MDM:  -Rash appears as an allergic reaction.  The patient is given Solu-Medrol and observed for period of time.  She continued to improve and I do feel she can be further evaluated as an outpatient.  The patient is placed on a prednisone burst and to continue antihistamines.  -The patient will follow up with their PCP and is to return for any new or worsening symptoms.  The patient is discharged in stable condition.   Final Impression: 1.  Allergic reaction
This spontaneous report was received from a certified medical assistant referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date, the patient was vaccinated with improperly stored doses of GARDASIL 9 lot number N004799 and expiration date of 15-NOV-2019 for prophylaxis (dose and route of administration were not reported) and M-M-R II rHA lot number L040960 with an expiration date of 16-OCT-2017 and lot number M045402 with an expiration date of 14-NOV-2018 for prophylaxis (dose and route of administration were not provided). The vaccine was exposed to a temperature excursion of 47.1°F with a time frame of 30 minutes. There was no previous temperature excursion. A "data logger" was involved. No adverse effects were reported. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1710USA006357: US-009507513-1710USA006358: US-009507513-1710USA006359: US-009507513-1709USA011980: US-009507513-1710USA006361: US-009507513-1710USA006362: US-009507513-1710USA006373: US-009507513-1710USA006364: US-009507513-1710USA006365: US-009507513-1710USA006366: US-009507513-1710USA006367: US-009507513-1710USA006368: US-009507513-1710USA006369: US-009507513-1710USA006370: US-009507513-1710USA006371: US-009507513-1710USA006372: US-009507513-1710USA006356: US-009507513-1710USA006355: US-009507513-1710USA006363.
make me sick; Initial information received on 18-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a patient via Social Media.  This case involves a male patient who noted INFLUENZA VACCINE made him sick.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via unknown route in unknown administration site as prophylactic vaccination. There will be no information available on the batch number for this case.  On an unknown date the patient developed a non-serious "make me sick (illness)" (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "Author/Reporter Comment: Oh hell no! They make me sick! If I don't get the shot I'm fine! Author/Reporter Comment: smart, I never get a shot and I don't get sick. I was talked into it ONCE and got sick! So I stay away from that crap! My God given immunity works great, also take lots of vitamins!"  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (make me sick).  At time of reporting, the outcome was Unknown for the event make me sick.
the following morning p/vax 31JAN96, pt started having sz;also exp gastroenteritis
Swelling, itching, redness, hardness, at vaccination site 7 days from injection
Information has been received as part of a class action suit concerning a pregnant female who was vaccinated with hepatitis B immune globulin. Subsequently, she had a son who suffered the toxic neurological effects of mercury poisoning. Upon internal review, the toxic neurological effects of mercury poisoning were considered to be other important medical events (OMIC). No further information is available. This report was received from the manufacturer's legal department on 12/13/04.
1st dose 2 years ago, 2nd not received; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 2 years ago (the day before reporting)).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 10-NOV-2022  Reporter's comment: The case was self reported by the patient. The patient reported that she was not getting second dose of Shingrix. No other information reported to agent by the patient. The reporter did not consent to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Information has been received from a physician concerning a 60 year old female with mold allergies and diabetes who in November 2010, was vaccinated IM with a 0.5 ml dose of PNEUMOVAX 23 "for disease prevention" (lot # not provided). In November 2010, the patient had a localized reaction to the injection of PNEUMOVAX 23, it was red warm and swollen at the injection site. Patient sought unspecified medical attention. Treatment given for AE included BENADRYL and TYLENOL and ice. AE improved after stopping therapy. On 08-DEC-2010, the patient recovered. No further information is available.
Subsequently the pt tested positive for opiates in her urine. The reporter notes that the level of opiates in the urine was "high". The pt sought unspecified medical treatment. Follow-up information indicated that the pt was in a substance abuse program and tested positive for opiates in her urine. The pt was vaccinated the day the urine sample was taken and the pt had denied using drugs. No further information is available.